Breast Adenocarcinoma Clinical Trials
4 recruiting
Showing 1–14 of 14 trials
Recruiting
Phase 1Phase 2
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma+97 more
Mayo Clinic132 enrolled1 locationNCT05269381
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Endometrial CancerPrimary Peritoneal CarcinomaNon-small Cell Lung Cancer+6 more
Genmab764 enrolled67 locationsNCT05579366
Recruiting
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
Estrogen Receptor-Positive Breast CarcinomaAnatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+4 more
Mayo Clinic25 enrolled1 locationNCT06401889
Recruiting
Not Applicable
Preoperative Radiation Therapy and Immediate Breast Reconstruction
Breast CarcinomaBreast NeoplasmsCancer+2 more
Cancer Research Antwerp180 enrolled6 locationsNCT06739655
Recruiting
A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing
Breast CancerBreast Adenocarcinoma
National and Kapodistrian University of Athens2,000 enrolled13 locationsNCT07389408
Recruiting
Phase 4
Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8+2 more
University of Washington68 enrolled1 locationNCT05183828
Recruiting
Not Applicable
Effects of Chemotherapy Treatment on Metaboreflex, Mechanoreflex, and Baroreflex Function: PROTECT-08B Study
Breast Adenocarcinoma
Centre Paul Strauss24 enrolled1 locationNCT07069790
Recruiting
Phase 1Phase 2
Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy
Breast Adenocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University96 enrolled1 locationNCT06596018
Recruiting
Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+3 more
Mayo Clinic230 enrolled1 locationNCT04517838
Recruiting
Not Applicable
Definitive Radiation Therapy for Inoperable Breast Cancer
Breast CancerBreast Adenocarcinoma
Alexander Stessin30 enrolled1 locationNCT07122713
Recruiting
Phase 2
High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8+2 more
City of Hope Medical Center36 enrolled1 locationNCT06538389
Recruiting
Personalization of External Beam Radiation Therapy in Localised Tumours
Breast AdenocarcinomaProstate Cancer (Adenocarcinoma)
European Institute of Oncology35 enrolled1 locationNCT07047495
Recruiting
Phase 2
Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer
Breast Adenocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University74 enrolled1 locationNCT06671262
Recruiting
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
Breast AdenocarcinomaBreast Cancer Stage IV
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano3,500 enrolled24 locationsNCT06805812